Comprehensive Cancer Centers of Nevada Research Department

Henderson, Nevada 89119

0 studies enrolling now · 2 studies all time

What they study most

HER2-positive Breast Cancer, Metastatic Colorectal Carcinoma

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal Cancer — Stopped early